NEW YORK--(BUSINESS WIRE)--The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired
common stock shares of Mallinckrodt plc (“Mallinckrodt”) (NYSE:
MNK)between the expanded class period of
July 14, 2014, and January 18, 2017. You are hereby
notified that Levi & Korsinsky has commenced a securities class
action entitled Patel v. Mallinckrodt plc, et al.,
1:17-cv-00171 in the U.S. District Court for the District of
Columbia (click here
to view the complaint). To get more information go to:

or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com
or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There
is no cost or obligation to you.

The complaint alleges that throughout the Class Period, Mallinckrodt and
its acting President and Chief Executive Officer, Mark Trudeau,
misrepresented the efficacy of Mallinckrodt’s business model and its
ability to maintain sustainable revenue. Specifically, the complaint
alleges that Defendants made false and/or misleading statements and/or
failed to disclose that Mallinckrodt engaged in unlawful anticompetitive
practices to maintain H.P. Acthar Gel’s (“Acthar”) monopoly status as
the only FDA-approved therapeutic preparation of adrenocorticotropic
hormone and that Mallinckrodt’s increasing reliance on Medicare and
Medicaid meant that the Company’s monopolistic Acthar revenue would be
threatened if the government took action to limit the price paid for the
drug by taxpayers.

Take Action: if you suffered a loss in Mallinckrodt you have until March
27, 2017to request that the Court appoint you as lead
plaintiff. Your ability to share in any recovery doesn’t require that
you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York,
California, Connecticut, and Washington D.C. The firm’s attorneys have
extensive expertise and experience representing investors in securities
litigation, and have recovered hundreds of millions of dollars for
aggrieved shareholders. Attorney advertising. Prior results do not
guarantee similar outcomes.